Clinical Trials Directory

Trials / Completed

CompletedNCT01863472

Catheter Ablation of Drug-refractory Persistent Atrial Fibrillation With the HeartLight(TM) Laser Balloon in Comparison With Irrigated Radiofrequency Current Ablation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
152 (actual)
Sponsor
Boris Schmidt · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Aim of the study is to compare the safety and efficacy of pulmonary vein isolation using the endoscopic ablation system in comparison to irrigated radiofrequency current ablation in patients with drug-refractory persistent atrial fibrillation.

Conditions

Interventions

TypeNameDescription
DEVICEHeartLight(TM) Laser BalloonWith the HeartLight(TM) Laser Balloon pulmonary vein isolation is done endoscopically guided
DEVICEirrigated radiofrequency current ablationThe irrigated radiofrequency current ablation is used for pulmonary vein isolation

Timeline

Start date
2013-06-01
Primary completion
2016-09-01
Completion
2016-11-01
First posted
2013-05-29
Last updated
2016-11-21

Locations

6 sites across 3 countries: Czechia, Germany, Spain

Source: ClinicalTrials.gov record NCT01863472. Inclusion in this directory is not an endorsement.

Catheter Ablation of Drug-refractory Persistent Atrial Fibrillation With the HeartLight(TM) Laser Balloon in Comparison (NCT01863472) · Clinical Trials Directory